CVS Health Co. (NYSE:CVS) Shares Sold by Americana Partners LLC

Americana Partners LLC decreased its position in shares of CVS Health Co. (NYSE:CVS) by 1.2% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 16,341 shares of the pharmacy operator’s stock after selling 205 shares during the quarter. Americana Partners LLC’s holdings in CVS Health were worth $965,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. USA Financial Formulas increased its holdings in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. acquired a new position in CVS Health in the fourth quarter valued at $32,000. First Community Trust NA raised its holdings in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the last quarter. Creekmur Asset Management LLC purchased a new position in shares of CVS Health during the fourth quarter worth about $34,000. Finally, Steph & Co. increased its position in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Trading Up 0.5 %

Shares of CVS opened at $57.24 on Friday. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The company has a market capitalization of $72.01 billion, a PE ratio of 10.06, a price-to-earnings-growth ratio of 0.80 and a beta of 0.52. The stock has a fifty day moving average of $58.50 and a two-hundred day moving average of $64.52. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same period in the prior year, the firm posted $2.21 earnings per share. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. As a group, analysts forecast that CVS Health Co. will post 6.52 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were given a $0.665 dividend. The ex-dividend date was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.65%. CVS Health’s dividend payout ratio is presently 46.75%.

Analysts Set New Price Targets

CVS has been the topic of several analyst reports. Baird R W upgraded CVS Health to a “hold” rating in a research note on Thursday, May 30th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Monday, August 19th. Argus cut their price objective on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Robert W. Baird assumed coverage on shares of CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Eleven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $73.24.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.